Acura Pharmaceuticals (ACUR) Short Interest Ratio & Short Volume → $21,000 in profits in six weeks? (From InvestorPlace) (Ad) Free ACUR Stock Alerts $0.0041 0.00 (0.00%) (As of 05/6/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Acura Pharmaceuticals Short Interest DataCurrent Short Volume6,300 sharesPrevious Short Volume6,300 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$17.64Short Interest Ratio / Days to Cover1.0Last Record DateApril 15, 2024Outstanding Shares66,350,000 sharesPercentage of Shares Shorted0.01%Today's Trading Volume0 sharesAverage Trading Volume3,641 sharesToday's Volume Vs. Average0% Short Selling Acura Pharmaceuticals ? Sign up to receive the latest short interest report for Acura Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatACUR Short Interest Over TimeACUR Days to Cover Over TimeACUR Percentage of Float Shorted Over Time Ad Stansberry ResearchDo NOT read if you believe in “woke” politicsI have to warn you, however: This CEO of a publicly traded company is not afraid to mince words. Many on Wall Street have refused to work with him.Everything you need to know is posted on our website here. Acura Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20246,300 shares $17.64 No ChangeN/A1 $0.00 3/31/20246,300 shares $15.75 No ChangeN/A31.5 $0.00 3/15/20246,300 shares $26.46 No ChangeN/A12.6 $0.00 2/29/20246,300 shares $13.23 No ChangeN/A12.6 $0.00 2/15/20246,300 shares $6.30 No ChangeN/A31.5 $0.00 1/15/20246,300 shares $6.93 -1.6%N/A1.1 $0.00 Get the Latest News and Ratings for ACUR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acura Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/20236,400 shares $0.00 No ChangeN/A0.7 $0.00 12/15/20236,400 shares $0.00 No ChangeN/A2.7 $0.00 11/30/20236,400 shares $0.00 No ChangeN/A32 $0.00 11/15/20236,400 shares $0.00 No ChangeN/A64 $0.00 10/31/20236,400 shares $0.00 No ChangeN/A1.4 $0.00 10/15/20236,400 shares $2.56 No ChangeN/A10.7 $0.00 9/30/20236,400 shares $2.56 No ChangeN/A32 $0.00 9/15/20236,400 shares $2.56 No ChangeN/A64 $0.00 8/31/20236,400 shares $2.56 No ChangeN/A12 $0.00 8/15/20236,400 shares $2.56 No ChangeN/A10.7 $0.00 7/31/20236,400 shares $3.84 No ChangeN/A1.6 $0.00 7/15/20236,400 shares $1.92 +1.6%N/A0.8 $0.00 6/30/20236,300 shares $1.89 No ChangeN/A5.7 $0.00 6/15/20236,300 shares $315.00 No ChangeN/A1.7 $0.05 5/31/20236,300 shares $315.00 No ChangeN/A4.8 $0.05 5/15/20236,300 shares $315.00 No ChangeN/A12.6 $0.05 4/30/20236,300 shares $315.00 No ChangeN/A63 $0.05 4/15/20236,300 shares $315.00 No ChangeN/A0.1 $0.05 3/31/20236,300 shares $315.00 No ChangeN/A1.4 $0.05 3/15/20236,300 shares $315.00 No ChangeN/A7 $0.05 2/28/20236,300 shares $315.00 No ChangeN/A6.3 $0.05 2/15/20236,300 shares $315.00 No ChangeN/A7.9 $0.05 1/31/20236,300 shares $315.00 No ChangeN/A10.5 $0.05 1/15/20236,300 shares $315.00 No ChangeN/A31.5 $0.05 12/30/20226,300 shares $315.00 No ChangeN/A1.2 $0.05 12/15/20226,300 shares $315.00 -4.6%N/A1.2 $0.05 11/30/20226,600 shares $330.00 -2.9%N/A16.5 $0.05 11/15/20226,800 shares $340.00 No ChangeN/A1 $0.05 10/31/20226,800 shares $34.00 No ChangeN/A3.2 $0.01 10/15/20226,800 shares $34.00 No ChangeN/A8.5 $0.01 9/30/20226,800 shares $68.00 No ChangeN/A68 $0.01 9/15/20226,800 shares $34.00 No ChangeN/A3.8 $0.01 8/31/20226,800 shares $68.00 No ChangeN/A0.1 $0.01 8/15/20226,800 shares $476.00 -37.6%N/A6.2 $0.072024 Oil Boom (Ad)Wall Street’s betting on new oil bull market… JP Morgan analysts have pegged the future price of oil at $380 per barrel. That would send oil companies skyrocketing.All the details are right here ACUR Short Interest - Frequently Asked Questions What is Acura Pharmaceuticals' current short interest? Short interest is the volume of Acura Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 6,300 shares of ACUR short. Learn More on Acura Pharmaceuticals' current short interest. What is a good short interest ratio for Acura Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ACUR shares currently have a short interest ratio of 1.0. Learn More on Acura Pharmaceuticals's short interest ratio. How does Acura Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Acura Pharmaceuticals: Aditxt, Inc. (10.83%), RespireRx Pharmaceuticals Inc. (0.00%), China SXT Pharmaceuticals, Inc. (11.61%), Sunshine Biopharma, Inc. (7.32%), Skinvisible, Inc. (0.05%), GlobeStar Therapeutics Co. (0.01%), Evelo Biosciences, Inc. (2.11%), SciSparc Ltd. (21.38%), Aptevo Therapeutics Inc. (9.10%), NovAccess Global Inc. (0.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Acura Pharmaceuticals stock? Short selling ACUR is an investing strategy that aims to generate trading profit from Acura Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Acura Pharmaceuticals? A short squeeze for Acura Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ACUR, which in turn drives the price of the stock up even further. How often is Acura Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACUR, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Aditxt Short Squeeze RespireRx Pharmaceuticals Short Squeeze China SXT Pharmaceuticals Short Squeeze Sunshine Biopharma Short Squeeze Skinvisible Short Squeeze GlobeStar Therapeutics Short Squeeze Evelo Biosciences Short Squeeze SciSparc Short Squeeze Aptevo Therapeutics Short Squeeze NovAccess Global Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ACUR) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersNo experience to confident trader, meet my student…Wealth Builders InstituteBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm Press2024 Oil BoomThe Oxford ClubMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceControversial CEO explains new way to amass wealthStansberry ResearchThe 2024 crypto bull run has already started — don’t get left behindInvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 Media